Oral yeast infections in immunocompromised and seriously diseased patients

References

• Hawkins C, Armstrong D. Fungal infections in the immunocompromised host. Clin Haematol 1984; 13: 599–630
   PubMedGoogle Scholar
• Heimdahl A, Mattsson T, Dahllöf G, Lönnquist B, Ringden O. The oral cavity as a port of entry for local and systemic early infections in patients treated with bone marrow transplantation. Oral Surg, (in press)
   Google Scholar
• Makkonen T A, Borthen L, Heimdahl A, Joensuu H, Lehtonen O-P, Nord C E. Oropharyngeal colonization with enteric Gram-negative rods and fungi in patients treated with radiotherapy of the head and neck. Br J Oral Maxillofac Surg 1989; 27: 334–40
   PubMed Web of Science ®Google Scholar
• Ringden O, Heimdahl A, Lönnquist B, Malmborg A-S, Wilczek H. Decreased incidence of viridans streptococcal septicaemia in allogenic bone marrow transplant recipients after the introduction of acyclovir. Lancet 1984; 1: 744
   PubMed Web of Science ®Google Scholar
• Heimdahl A, Nord C E. Colonization of the oropharynx with pathogenic microorganisms—A potential risk factor for infection in compromised patients. Chemiotherapia 1985; 4: 186–91
   PubMedGoogle Scholar
• Mattson T, Heimdahl A, Dahllöf G, Ringden O. Hur fungerar immunförsvaret och vilka brister medför ökad infektionsrisk. Tandlakartidningen 1989; 81: 208–17
   PubMedGoogle Scholar
• Epstein J B, Kimura L H, Menard T W, Truelove E L, Pearsall N N. Effects of specific antibodies on the interaction between the fungus Candida albicans and human oral mucosa. Arch Oral Biol 1982; 27: 469–74
   PubMed Web of Science ®Google Scholar
• Johanson W G, Pierce A K, Sanford J P. Changing pharyngeal bacterial flora of hospitalized patients. Emergence of gram-negative bacilli. N Engl J Med 1969; 281: 1137–40
   PubMed Web of Science ®Google Scholar
• Kostiala I, Kostiala A AI, Kahanpaa A. Oral mycoses and their treatment. Acta Odontol Scand 1979; 37: 87–101
   PubMed Web of Science ®Google Scholar
• Nord C E, Kager L, Heimdahl A. The impact of antimicrobial agents on the gastrointestinal microflora and the risk of infections. Am J Med 1984; 76(5A)99–106
   PubMed Web of Science ®Google Scholar
• Schimpff S C, Young V M, Greene W H, Vermeulen G D, Moody M R, Wiernik P H. Origin of infection in acute nonlymphocytic leukemia. Significance of hospital acquisition of potential pathogens. Ann Intern Med 1972; 77: 707–14
   PubMed Web of Science ®Google Scholar
• Schimpff S C, Moody M M, Young V M. Relationship of colonization with Pseudomonas aeruginosa to development of Pseudomonas bacteremia in cancer patients. Antimicrob Agents Chemother 1970; 10: 240–44
   PubMedGoogle Scholar
• Kiehn T E, Edwards F F, Armstrong D. The prevalence of yeasts in clinical specimens from cancer patients. Am J Clin Pathol 1980; 73: 518–21
   PubMed Web of Science ®Google Scholar
• Kostiala I, Kostiala A AI, Elonen E, Valtonen V V, Vuopio P. Comparison of clotrimazole and chlorhexidine in the topical treatment of acute fungal stomatitis in patients with hematological malignancies. Curr Ther Res 1982; 31: 752–63
   Google Scholar
• Olsen I, Stenderup A. Clinical-mycologic diagnosis of oral yeast infections. Acta Odontol Scand 1990; 48: 11–8
   PubMed Web of Science ®Google Scholar
• Hopfer R L, Orengo A, Chesnut S, Wenglar M. Radiometric detection of yeasts in blood cultures of cancer patients. J Clin Microbiol 1980; 12: 329–31
   PubMedGoogle Scholar
• Histopathology of mycotic diseases, F Chandler, W Kaplan, L Ajello. Wolfe Medical, London 1980
   Google Scholar
• Penn R, Lambert R, George R. Invasive fungal infections. The use of serologic tests in diagnosis and management. Arch Intern Med 1983; 143: 1215–20
   PubMedGoogle Scholar
• Müller H-L. Serologische diagnostik der Mykosen. Chemotherapy 1976; 22: 87–102, suppl 1
   Google Scholar
• Kostiala I, Kostiala A AI, Larinkari U, Valtonen V V, Miettinen A. Antibodies against antigens of Candida albicans in patients with fungaemia and bacteraemia, studied by ELISA, precipitation, passive haemagglutination and immunofluorescence techniques. J Med Microbiol 1981; 14: 483–92
   PubMed Web of Science ®Google Scholar
• DeRepentigny L, Reiss E. Current trends in immunodiagnosis of candidiasis and aspergillosis. Rev Infect Dis 1984; 6: 301–12
   PubMedGoogle Scholar
• Kostiala I, Kostiala A AI, Kahanpaa A, Elonen E. Acute fungal stomatitis in patients with hematologic malignancies: quantity and species of fungi. J Infect Dis 1982; 145: 101
   Google Scholar
• Budtz-Jörgensen E. Etiology, pathogenesis, therapy and prophylaxis of oral yeast infections. Acta Odontol Scand 1990; 48: 61–9
   PubMed Web of Science ®Google Scholar
• Williams C, Whitehous J M, Lister T A, Wrigley P F. Oral anticandidal prophylaxis in patients undergoing chemotherapy for acute leukemia. Med Pediatr Oncol 1977; 3: 275–80
   PubMedGoogle Scholar
• Pizzuto J, Conte G, Aviles A, Ambriz R, Morales M. Nystatin prophylaxis in leukemia and lymphoma. N Engl J Med 1978; 299: 661–2
   PubMedGoogle Scholar
• DeGregorio M W, Lee W MF, Ries C A. Candida infections in patients with acute leukemia: Ineffectiveness of nystatin prophylaxis and relationship between oropharyngeal and systemic candidiasis. Cancer 1982; 50: 2780–4
   PubMed Web of Science ®Google Scholar
• Levine A S, Siegel S E, Schreiber A D. Protected environments and prophylactic antibiotics. A prospective controlled study of their utility in the therapy of acute leukemia. N Engl J Med 1973; 288: 477–83
   PubMed Web of Science ®Google Scholar
• Kurrle E, Bhaduri S, Krieger D. Risk factors for infections of the oropharynx and the respiratory tract in patients with acute leukemia. J Infect Dis 1981; 144: 128–36
   PubMed Web of Science ®Google Scholar
• Heimdahl A, Garthon G, Groth C G. Selective decontamination of alimentary tract microbial flora in patients treated with bone marrow transplantation. Scand J Infect Dis 1984; 16: 51–60
   PubMed Web of Science ®Google Scholar
• Dekker A, Rozenberg-Arska M, Sixma J, Verhoef J. Prevention of infection by trimethoprim-sulfamethoxazole plus amphotericin B in patients with acute non-lymphocytic leukemia. Ann Intern Med 1981; 95: 555–9
   PubMed Web of Science ®Google Scholar
• Wade J C, Schimpff S C, Hargadon M T, Fortner C L, Young V M, Wiernik P H. A comparison of trimethoprim-sulfamethoxazole plus nystatin with gentamicin plus nystatin in the prevention of infections in acute leukemia. N Engl J Med 1981; 304: 1057–62
   PubMed Web of Science ®Google Scholar
• Wade J C, De Jongh C A, Newman K A, Crowley J, Wiernik P H, Schimpff S C. Selective antimicrobial modulation as prophylaxis against infection during granulocytopenia: Trimethoprim-sulfamethoxazole vs. nalidixic acid. J Infect Dis 1983; 147: 624–34
   PubMed Web of Science ®Google Scholar
• Acuna G, Winston D J, Young L S. Ketoconazole prophylaxis of fungal infections in the granulocytopenic patient: a double-blind, randomized controlled trial. Twenty-first Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, Illinois, November, 1981, Abstract 852
   Google Scholar
• Brincker H. Prevention of mycosis in granulocytopenic leukemia patients with prophylactic ketoconazole treatment. Twenty-first Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, Illinois, November, 1981, Abstract 850
   Google Scholar
• Horsburgh C, Kirkpatrick C. Long-term therapy of chronic mucocutaneous candidosis with ketoconazole: experience with twenty-one patients. Am J Med 1983; 74: 23–9
   PubMedGoogle Scholar
• Chave J P, Cajot A, Bille J, Glauser M P. Single-dose therapy for oral candidiasis with fluconazole in HIV-infected adults: a pilot study. J Infect Dis 1989; 159: 806–7
   PubMedGoogle Scholar
• Langslet A, Olsen I, Lie S O, Løkken P. Chlorhexidine treatment of oral candidiasis in seriously diseased children. Acta Paediatr Scand 1974; 63: 809–11
   PubMed Web of Science ®Google Scholar
• Spijkerveet F KL, Van Saene H KF, Panders A K. Effect of chlorhexidine rinsing on the oropharyngeal ecology in patients with head and neck cancer who have irradiation mucositis. Oral Surg 1989; 67: 154–61
   PubMedGoogle Scholar
• Borthen-Svinhufvud L, Heimdahl A, Nord C E. Effect of topical administration of vancomycin versus chlorhexidine on viridans streptococci in the oral cavity. Oral Surg 1988; 66: 304–9
   PubMedGoogle Scholar
• Barkvoll P, Attramadal A. Effect of nystatin and chlorhexidine digluconate on Candida albicans. Oral Surg 1989; 67: 297–81
   Google Scholar
• Lopez-Bernstein G, Fainstein V, Hopfer R. Liposomal amphotericin B for the treatment of systemic fungal infections in patients with cancer: a preliminary study. J Infect Dis 1985; 151: 704–10
   PubMedGoogle Scholar